Literature DB >> 36057892

Small leucine zipper protein functions as a modulator for metabolic reprogramming of colorectal cancer cells by inducing nutrient stress-mediated autophagy.

Suhyun Kim1, Minseok Oh1, Minsoo Kang1, Jesang Ko2.   

Abstract

In multiple cancers, autophagy promotes tumor development by recycling intracellular components into metabolic pathways. Autophagy-induced metabolic reprogramming and plasticity lead to cancer cell survival and resistance to anticancer therapy. We investigated the role of small leucine zipper protein (sLZIP) in autophagy and cell survival under nutrient-deficient conditions in colorectal cancer (CRC). sLZIP was induced by nutrient stress and increased the transcription of microtubule-associated protein 1A/1B-light chain 3 (LC3), by directly binding to its promoter. Under nutrient stress conditions, sLZIP activated autophagy and promoted the survival of CRC cells. sLZIP induced metabolic reprogramming of CRC cells, to activate glutaminolysis and the tricarboxylic acid cycle. sLZIP also enhanced the autophagic degradation of Keap1 and the nuclear accumulation of Nrf2, leading to NQO1 expression, for maintenance of redox homeostasis. sLZIP-knockout CRC cells exhibited impaired autophagy induction in the glycolytic inhibition state. Xenograft mice lacking sLZIP showed decreased tumor growth, by rendering CRC cells sensitive to glycolysis inhibition. The expression of sLZIP and LC3B was highly elevated in tumors of CRC patients compared to that in normal tissues, and correlated with the progression of CRC. These findings suggest that sLZIP drives autophagy and metabolic reprogramming to promote colorectal tumorigenesis.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Autophagy; Colorectal cancer; Metabolic reprogramming; Transcriptional regulation

Mesh:

Substances:

Year:  2022        PMID: 36057892     DOI: 10.1007/s00018-022-04535-4

Source DB:  PubMed          Journal:  Cell Mol Life Sci        ISSN: 1420-682X            Impact factor:   9.207


  32 in total

1.  PKM2 isoform-specific deletion reveals a differential requirement for pyruvate kinase in tumor cells.

Authors:  William J Israelsen; Talya L Dayton; Shawn M Davidson; Brian P Fiske; Aaron M Hosios; Gary Bellinger; Jie Li; Yimin Yu; Mika Sasaki; James W Horner; Laura N Burga; Jianxin Xie; Michael J Jurczak; Ronald A DePinho; Clary B Clish; Tyler Jacks; Richard G Kibbey; Gerburg M Wulf; Dolores Di Vizio; Gordon B Mills; Lewis C Cantley; Matthew G Vander Heiden
Journal:  Cell       Date:  2013-10-10       Impact factor: 41.582

2.  Global metabolic reprogramming of colorectal cancer occurs at adenoma stage and is induced by MYC.

Authors:  Kiyotoshi Satoh; Shinichi Yachida; Masahiro Sugimoto; Minoru Oshima; Toshitaka Nakagawa; Shintaro Akamoto; Sho Tabata; Kaori Saitoh; Keiko Kato; Saya Sato; Kaori Igarashi; Yumi Aizawa; Rie Kajino-Sakamoto; Yasushi Kojima; Teruaki Fujishita; Ayame Enomoto; Akiyoshi Hirayama; Takamasa Ishikawa; Makoto Mark Taketo; Yoshio Kushida; Reiji Haba; Keiichi Okano; Masaru Tomita; Yasuyuki Suzuki; Shinji Fukuda; Masahiro Aoki; Tomoyoshi Soga
Journal:  Proc Natl Acad Sci U S A       Date:  2017-08-28       Impact factor: 11.205

3.  Targeting mitochondrial glutaminase activity inhibits oncogenic transformation.

Authors:  Jian-Bin Wang; Jon W Erickson; Reina Fuji; Sekar Ramachandran; Ping Gao; Ramani Dinavahi; Kristin F Wilson; Andre L B Ambrosio; Sandra M G Dias; Chi V Dang; Richard A Cerione
Journal:  Cancer Cell       Date:  2010-09-14       Impact factor: 31.743

4.  Intestinal inhibition of Atg7 prevents tumour initiation through a microbiome-influenced immune response and suppresses tumour growth.

Authors:  Jonathan Lévy; Wulfran Cacheux; Medhi Ait Bara; Antoine L'Hermitte; Patricia Lepage; Marie Fraudeau; Coralie Trentesaux; Julie Lemarchand; Aurélie Durand; Anne-Marie Crain; Carmen Marchiol; Gilles Renault; Florent Dumont; Franck Letourneur; Myriam Delacre; Alain Schmitt; Benoit Terris; Christine Perret; Mathias Chamaillard; Jean-Pierre Couty; Béatrice Romagnolo
Journal:  Nat Cell Biol       Date:  2015-07-27       Impact factor: 28.824

Review 5.  The Emerging Hallmarks of Cancer Metabolism.

Authors:  Natalya N Pavlova; Craig B Thompson
Journal:  Cell Metab       Date:  2016-01-12       Impact factor: 27.287

6.  Transcriptional and metabolic rewiring of colorectal cancer cells expressing the oncogenic KRASG13D mutation.

Authors:  Theodosia Charitou; Sriganesh Srihari; Miriam A Lynn; Mohamed-Ali Jarboui; Erik Fasterius; Max Moldovan; Senji Shirasawa; Toshiyuki Tsunoda; Marius Ueffing; Jianling Xie; Jin Xin; Xuemin Wang; Christopher G Proud; Karsten Boldt; Cristina Al-Khalili Szigyarto; Walter Kolch; David J Lynn
Journal:  Br J Cancer       Date:  2019-05-28       Impact factor: 7.640

7.  Fibulin 2 Is Hypermethylated and Suppresses Tumor Cell Proliferation through Inhibition of Cell Adhesion and Extracellular Matrix Genes in Non-Small Cell Lung Cancer.

Authors:  Yunxia Ma; Miljana Nenkov; Desiree Charlotte Schröder; Mohamed Abubrig; Nikolaus Gassler; Yuan Chen
Journal:  Int J Mol Sci       Date:  2021-10-31       Impact factor: 5.923

8.  Metabolite profiling of human colon carcinoma--deregulation of TCA cycle and amino acid turnover.

Authors:  Carsten Denkert; Jan Budczies; Wilko Weichert; Gert Wohlgemuth; Martin Scholz; Tobias Kind; Silvia Niesporek; Aurelia Noske; Anna Buckendahl; Manfred Dietel; Oliver Fiehn
Journal:  Mol Cancer       Date:  2008-09-18       Impact factor: 27.401

9.  RACK1 promotes tumorigenicity of colon cancer by inducing cell autophagy.

Authors:  Ta Xiao; Wei Zhu; Wei Huang; Shan-Shan Lu; Xin-Hui Li; Zhi-Qiang Xiao; Hong Yi
Journal:  Cell Death Dis       Date:  2018-11-19       Impact factor: 8.469

Review 10.  Functions and Implications of Autophagy in Colon Cancer.

Authors:  Samantha N Devenport; Yatrik M Shah
Journal:  Cells       Date:  2019-10-30       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.